Alcon Independent Director Committee Notes RiskMetrics Group's and Glass Lewis' Opposition to Election of Novartis' Designees to Alcon's Board of Directors.
Business Wire › August 02, 2010
Linked as:
Extract
Alcon Independent Director Committee Notes RiskMetrics Group's and Glass Lewis' Opposition to Election of Novartis' Designees to Alcon's Board of Directors.
* RiskMetrics and Glass Lewis Recommend Shareholders Vote Against Novartis' Board Designees at Extraordinary General Meeting
* Three Leading Corporate Governance Experts Concerned with Novartis' Attempt to Force Unfair and Coercive Merger Offer on Minority Shareholders HUENENBERG, Switzerland -- The Alcon Independent Director Committee (the "IDC") today announced that RiskMetri...See the full content of this document
Sponsored links
